Bcid panel-rfit-ASY-0126

Ended Awarded Last action

Contract number
W81K0019F0434
Awardee
Awarding agency
Obligated
$1,599,124

Award facts

Opportunity
Contract value 100% obligated
$1,599,123.75 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Funding agency
Defense Health Agency Department of Defense
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Fort Hood, TX 76544, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00016 · Respiratory RP2.1 panel product # 423742 -$213,818
Funding Only Action P00015 $542,471
Funding Only Action P00014 -$277,247
Funding Only Action P00013 -$32,702
Exercise an Option P00012 $0
Funding Only Action P00011 · BCID2 rfit-ASY-0147. $538,523
Supplemental Agreement for work within scope P00010 -$109,685
Exercise an Option P00009 · Bioscience test kits and controls. Exercise option year three. $0
Funding Only Action P00008 -$186,285
Funding Only Action P00007 $542,471
Funding Only Action P00006 -$368,397
Exercise an Option P00005 $0
Funding Only Action P00004 $542,471
Exercise an Option P00003 $0
Supplemental Agreement for work within scope P00002 $78,851
Funding Only Action P00001 $542,471
Original award $0
Show all 17

About this award

Written by GovTribe AI ·

This is a delivery order awarded by the Defense Health Agency to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The contract, valued at $1,599,123.75, is a firm fixed-price order for a BCID PANEL-RFIT-ASY-0126 item under Biofire's General Services Administration Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The award has an ultimate completion date of September 30, 2024. Biofire Diagnostics has received numerous federal contract awards as a prime contractor to provide a variety of infectious disease testing products and services, including to the Department of Veterans Affairs, Department of Health and Human Services, and Department of State. This order does not have a set-aside designation.

Quick answers

Who was awarded contract W81K0019F0434?

W81K0019F0434 was awarded to Biofire Diagnostics LLC by Medical Command (Department of the Army) on October 1, 2019.

How much is contract W81K0019F0434 worth?

The government has obligated $1,599,124 on W81K0019F0434.

Which agency awarded contract W81K0019F0434?

Medical Command (Department of the Army) awarded W81K0019F0434, with funding from Defense Health Agency (Department of Defense).

Is contract W81K0019F0434 an order under another contract?

Yes. W81K0019F0434 is a delivery order under V797D30085, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).

Was contract W81K0019F0434 competed?

The extent of competition for W81K0019F0434 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login